Social Phobia (Social Anxiety Disorder)
- 1.8k Downloads
Social phobia is a common disorder with an approximate 13% lifetime prevalence . Social phobia may also be referred to as social anxiety disorder (SAD). Onset of SAD is usually in adolescence or early adulthood and may be acute or insidious . The acute onset follows a specific humiliating event that likely has occurred in childhood or early adolescence. Social anxiety disorder in its milder form may be a common event in many people.
Almost everyone has experienced apprehension when speaking in front of the class during one's early school years. For some, the fear, anxiety, and apprehension may persist, expand, and worsen into adulthood, resulting in avoidance behaviors and considerable disability. Social anxiety often creates a hindrance to success and happiness. Social anxiety, panic disorder, and posttraumatic stress disorder together may have more impact on quality of life and poorer levels of functioning than the combined effect of chronic medical illnesses and depression ....
KeywordsAnxiety Disorder Social Anxiety Social Phobia Atypical Antipsychotic Social Anxiety Disorder
- 1.Hollander E, Simeon D. Anxiety disorders. In: Hales R, Yudofsky S, eds. Textbook of Clinical Psychiatry. Washington, DC: American Psychiatric Publishing, 2003:570–582.Google Scholar
- 3.Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision. Washington, DC: American Psychiatric Association, 2000:215–216.Google Scholar
- 6.Westernberg H. The nature of social anxiety disorder. J Clin Psychiatry 1998;59(suppl 17):20–26.Google Scholar
- 7.Sajatovic M, Ramirez L. Rating Scales in Mental Health, 2nd ed. Hudson, OH: Lexicomp, 2003:45–52.Google Scholar
- 8.Shelton R. Anxiety disorders. In: Ebert M, Loosen P, Nurcombe B, eds. Current Diagnosis and Treatment in Psychiatry. New York: Lange Medical Books/McGraw-Hill, 2000:328–340.Google Scholar
- 10.Chourinard G. The search for new off-label indications for antidepres-sant, antianxiety, antipsychotic and anticonvulsant drugs. J Psychiatry Neurosci 2006;31(3):168–176.Google Scholar